Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.050
-0.060 (-1.93%)
Dec 20, 2024, 4:00 PM EST - Market closed
Organogenesis Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 455.04 | 433.14 | 450.89 | 467.36 | 338.3 | 260.98 | Upgrade
|
| Revenue | 455.04 | 433.14 | 450.89 | 467.36 | 338.3 | 260.98 | Upgrade
|
| Revenue Growth (YoY) | 1.34% | -3.94% | -3.52% | 38.15% | 29.63% | 34.91% | Upgrade
|
| Cost of Revenue | 112.46 | 106.48 | 105.02 | 114.2 | 87.32 | 75.95 | Upgrade
|
| Gross Profit | 342.58 | 326.66 | 345.87 | 353.16 | 250.98 | 185.03 | Upgrade
|
| Selling, General & Admin | 280.12 | 265.96 | 281.54 | 249.48 | 203.37 | 200.09 | Upgrade
|
| Research & Development | 50.51 | 44.38 | 39.76 | 30.74 | 20.09 | 14.8 | Upgrade
|
| Operating Expenses | 330.63 | 310.34 | 321.3 | 280.22 | 223.46 | 214.89 | Upgrade
|
| Operating Income | 11.95 | 16.32 | 24.57 | 72.94 | 27.52 | -29.85 | Upgrade
|
| Interest Expense | -2.11 | -2.19 | -2.01 | -7.24 | -11.28 | -9 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | 0.06 | -0.01 | -0.01 | 0.1 | 2.15 | Upgrade
|
| EBT Excluding Unusual Items | 9.86 | 14.19 | 22.55 | 65.69 | 16.34 | -36.7 | Upgrade
|
| Merger & Restructuring Charges | -1.92 | -3.8 | -2.27 | -4.7 | -0.62 | - | Upgrade
|
| Asset Writedown | -22.8 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 2.1 | 2.04 | -1.86 | Upgrade
|
| Pretax Income | -14.86 | 10.39 | 20.28 | 63.09 | 17.76 | -38.56 | Upgrade
|
| Income Tax Expense | -7.48 | 5.45 | 4.75 | -31.12 | 0.53 | 0.15 | Upgrade
|
| Earnings From Continuing Operations | -7.38 | 4.95 | 15.53 | 94.2 | 17.23 | -38.71 | Upgrade
|
| Net Income to Company | -7.38 | 4.95 | 15.53 | 94.2 | 17.23 | -38.71 | Upgrade
|
| Net Income | -7.38 | 4.95 | 15.53 | 94.2 | 17.23 | -38.71 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.57 | Upgrade
|
| Net Income to Common | -7.38 | 4.95 | 15.53 | 94.2 | 17.23 | -39.28 | Upgrade
|
| Net Income Growth | - | -68.16% | -83.51% | 446.61% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 132 | 131 | 130 | 128 | 108 | 93 | Upgrade
|
| Shares Outstanding (Diluted) | 132 | 133 | 132 | 134 | 111 | 93 | Upgrade
|
| Shares Change (YoY) | -0.37% | 0.27% | -0.96% | 20.03% | 19.95% | 33.93% | Upgrade
|
| EPS (Basic) | -0.06 | 0.04 | 0.12 | 0.73 | 0.16 | -0.42 | Upgrade
|
| EPS (Diluted) | -0.06 | 0.04 | 0.12 | 0.70 | 0.15 | -0.42 | Upgrade
|
| EPS Growth | - | -68.44% | -82.94% | 366.67% | - | - | Upgrade
|
| Free Cash Flow | 3.89 | 6.55 | -9.04 | 30.76 | -12.21 | -39.51 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.05 | -0.07 | 0.23 | -0.11 | -0.43 | Upgrade
|
| Gross Margin | 75.29% | 75.42% | 76.71% | 75.56% | 74.19% | 70.90% | Upgrade
|
| Operating Margin | 2.63% | 3.77% | 5.45% | 15.61% | 8.14% | -11.44% | Upgrade
|
| Profit Margin | -1.62% | 1.14% | 3.44% | 20.16% | 5.09% | -15.05% | Upgrade
|
| Free Cash Flow Margin | 0.85% | 1.51% | -2.00% | 6.58% | -3.61% | -15.14% | Upgrade
|
| EBITDA | 28.74 | 31.69 | 35.3 | 83.67 | 35.7 | -20.03 | Upgrade
|
| EBITDA Margin | 6.32% | 7.32% | 7.83% | 17.90% | 10.55% | -7.67% | Upgrade
|
| D&A For EBITDA | 16.79 | 15.37 | 10.73 | 10.73 | 8.18 | 9.83 | Upgrade
|
| EBIT | 11.95 | 16.32 | 24.57 | 72.94 | 27.52 | -29.85 | Upgrade
|
| EBIT Margin | 2.63% | 3.77% | 5.45% | 15.61% | 8.14% | -11.44% | Upgrade
|
| Effective Tax Rate | - | 52.42% | 23.42% | - | 2.98% | - | Upgrade
|
| Advertising Expenses | - | 5.23 | 4.81 | 5.52 | 2.72 | 1.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.